NPM1 and acute myeloid leukemia: In multivariate analysis, NPM1 mutation was significantly and independently associated with a better relapse-free survival whereas ECOG performance status >1, adverse-risk cytogenetics, FLT3-ITD mutation and secondary AML were associated with a poorer relapse-free survival (Table 2).